In the last trading session, 1.3 million Windtree Therapeutics Inc (NASDAQ:WINT) shares changed hands as the company’s beta touched 0.71. With the company’s per share price at $0.45 changed hands at -$0.01 or -1.43% during last session, the market valuation stood at $1.65M. WINT’s last price was a discount, traded about -163773.33% off its 52-week high of $737.43. The share price had its 52-week low at $0.36, which suggests the last value was 20.0% up since then. When we look at Windtree Therapeutics Inc’s average trading volume, we note the 10-day average is 1.96 million shares, with the 3-month average coming to 2.44 million.
Analysts gave the Windtree Therapeutics Inc (WINT) stock a consensus recommendation rating of Buy, calculated at a mean rating of 3.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended WINT as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight.
Windtree Therapeutics Inc (NASDAQ:WINT) trade information
Instantly WINT was in red as seen at the end of in last trading. With action -21.14%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -99.73%, with the 5-day performance at -21.14% in the red. However, in the 30-day time frame, Windtree Therapeutics Inc (NASDAQ:WINT) is -46.48% down. Looking at the short shares, we see there were 0.93 million shares sold at short interest cover period of 0.17 days.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 75.28%.
WINT Dividends
Windtree Therapeutics Inc is expected to release its next quarterly earnings report on 2025-Apr-15.
Windtree Therapeutics Inc (NASDAQ:WINT)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.01% of Windtree Therapeutics Inc shares while 1.39% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 1.39%.
